Grant

A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer

Active

$494.2K Funding

8 People

External

Aaron Scott
Principal Investigator (PI)
Medicine﹒Associate Professor, Medicine - (Clinical Scholar Track)
Hina Arif Tiwari
Co-Investigator (COI)
Pathology and Lab Medicine﹒Professor
Rachna Shroff
Co-Investigator (COI)
Medicine﹒Professor
Brianna Denton
(CD)
Cancer Center Division﹒Research Compliance Manager I
Brianna Loughran
(CD)
Cancer Center Division﹒Clinical Research Coordinator II
Bryan Clines
(CD)
Cancer Center Division﹒Research Compliance Administrator III
Diana Dawson
(CD)
Cancer Center Division﹒Research Compliance Administrator II
Umbreen Rozell
Co-Investigator (COI)
Medicine﹒Assistant Clinical Professor, Medicine - (Clinical Series Track)